19-35157427-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014164.6(FXYD5):c.68C>T(p.Thr23Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000441 in 1,575,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014164.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FXYD5 | NM_014164.6 | c.68C>T | p.Thr23Met | missense_variant | 3/9 | ENST00000392219.7 | NP_054883.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FXYD5 | ENST00000392219.7 | c.68C>T | p.Thr23Met | missense_variant | 3/9 | 1 | NM_014164.6 | ENSP00000376053.2 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000263 AC: 66AN: 251238Hom.: 0 AF XY: 0.000272 AC XY: 37AN XY: 135792
GnomAD4 exome AF: 0.000457 AC: 650AN: 1422824Hom.: 0 Cov.: 24 AF XY: 0.000437 AC XY: 310AN XY: 710090
GnomAD4 genome AF: 0.000289 AC: 44AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.68C>T (p.T23M) alteration is located in exon 3 (coding exon 2) of the FXYD5 gene. This alteration results from a C to T substitution at nucleotide position 68, causing the threonine (T) at amino acid position 23 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at